Belgium· BE-AMP-SAM662768-00
Kacital 1080 mg
A potassium citrate product containing tripotassium citrate monohydrate, registered in Belgium by XGX Pharma. The same ATC class is registered in 9 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Potassium citrate is registered in 9 of 19 countries.
Countries holding a registration under ATC A12BA02 (potassium citrate), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 5 of them publish a price we can compare per daily dose
Potassium citrate · ATC A12BA02
9 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
Price per daily dose
What a daily dose of potassium citrate costs, country by country.
Normalised to the WHO defined daily dose (4 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Potassium citrate · price per daily dose (4 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.74
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Tripotassium Citrate Monohydrate
- Manufacturer
- XGX Pharma
- Country
- Belgium (BE)
- ATC code
- A12BA02
- ATC class
- Potassium citrate
- Defined daily dose
- 4 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
201 interactions on record for potassium citrate.
Graded by severity as the source publishes them — 108 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Potassium citrate · interactions on record
201 records
- 108 severe
- 67 moderate
- 26 minor
Most severe, free to view
- DicycloverineA03AA07severe
- PropanthelineA03AB05severe
- MepenzolateA03AB12severe
- TrospiumA03AB20severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Potassium citrate in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayAcalka pharmaprimFerrer Internacional S.A.
- United StatesPOTASSIUM CITRATERising Pharma Holdings, Inc.
- CanadaUROCIT-KMISSION PHARMACAL COMPANY
- IrelandKacital 1080 mg modified-release tabletsXGX Pharma ApS
- NetherlandsKacital 1080 mg, tabletten met gereguleerde afgifteXGX Pharma ApS
- PolandNefrocitranTarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- United KingdomAad K 600mg (8mmol) Slow Release tabletsEssential-Healthcare Ltd
- CzechiaARDEAELYTOSOL CONC. KALIUMCHLORID 7,45%ARDEAPHARMA, a.s., Ševětín
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Kacital, Kaliumchlorid B. Braun
- Bulgaria · Калиев Хлорид Браун, Нефромелтар
- Cyprus · Sopa-K, Καλιο Χλωριουχο Demo
- Czechia · Ardeaelytosol, Kalium Chloratum Biomedica
- Germany · 1 M-Kaliumchlorid-Lösung Deltamedica, 1m-Kaliumchlorid-Lösung Fresenius
- Denmark · Alkacit, Kaleorid
- Estonia · Potassium Chloride Braun, Potassium Chloride Kabi
- Spain · Acalka, Acetato De Potasio B.Braun
- Finland · Addex-Kaliumklorid, Alkacit
- France · Chlorure De Potassium B. Braun, Chlorure De Potassium Cooper
- United Kingdom (Northern Ireland) · Cystopurin, Kay-Cee-L
- Greece · Potassium Chloride Demo Αβεε, Potassium Chloride Noridem
- Croatia · 1 M Kalijev Klorid Hztm, Kalijev Klorid B. Braun
- Hungary · Kaldyum, Kalii Citratis Fono Viii. Naturland
- Ireland · Cystopurin, Kacital
- Iceland · Alkacit, Kaleorid
- Italy · Kcl-Retard, Lento-Kalium
- Lithuania · Potassium Chloride Braun, Potassium Chloride Fresenius
- Luxembourg · Kalinor-Retard P, Kaliumchlorid Braun
- Latvia · Potassium Chloride Braun, Potassium Chloride Kabi
- Malta · Cystopurin, Potassium Chloride Monico
- Netherlands · Kacital, Kaliumchloride
- Norway · Addex, Addex Kaliumklorid
- Poland · Kaldyum, Kalipoz Prolongatum
- Portugal · Acalka, Cloreto De Potássio Basi
- Romania · Clorură De Potasiu Braun, Clorură De Potasiu Kabi
- Sweden · Addens-Kaliumklorid B. Braun, Addex-Kaliumklorid
- Slovenia · Kalijev Klorid B. Braun, Kalijev Klorid Jadran
- Slovakia · Kaldyum, Kalium Chloratum Biomedica
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a1656c26-ba59-4b4a-a2d8-f21e58a3ffcc GET /v1/drugs/a1656c26-ba59-4b4a-a2d8-f21e58a3ffcc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Modified-release tablet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Kacital 1080 mg",
"name_fr": "Kacital 1080 mg",
"name_nl": "Kacital 1080 mg",
"amp_code": "SAM662768-00",
"strengths": [
"1080.0000",
"1080.0000",
"10.0000",
"10.0000"
],
"pack_count": 1,
"substances": [
"Tripotassium Citrate Monohydrate",
"Tripotassium Citrate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Potassium Citrate",
"authorisation_numbers": [
"BE662768"
]
}See everything about potassium citrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.